Bazaar Updates
Closed · opens Mon 09:00 IST
Manage your watchlist and alerts here. Voting and comments need desktop.
Press ? for shortcuts
Report
Be the first to vote

Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October ↗

Sun Pharmaceutical Industries will hold a Board meeting on October 12, 2026, to approve the issuance of non-convertible debentures worth up to ₹15,000 crore to fund a bridge loan for acquiring Organon & Co.

From Livemint Markets

Read full story ↗

Open on desktop to take part.

0 comments

Comments are posted by users and are not reviewed by Bazaar Updates.

Open on desktop to take part.

No comments yet.